연구동향 분석

동종 조혈모세포 이식환자에서 Pentoxifylline의 간정맥폐쇄성 질환 예방효과

김남희 이소영 김재송 손은선 2019년

논문상세정보
인용/피인용
' 동종 조혈모세포 이식환자에서 Pentoxifylline의 간정맥폐쇄성 질환 예방효과' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • VOD (Veno-Occlusive Disease)
  • allogeneic hematopoietic stem cell transplantation
  • pentoxifylline
  • prophylaxis
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
43 0

0.0%

' 동종 조혈모세포 이식환자에서 Pentoxifylline의 간정맥폐쇄성 질환 예방효과' 의 참고문헌

  • Sinusoidal obstruction syndrome/venoocclusive disease : current situation and perspectives-a position statement from the European Society for Blood and Marrow Transplantation(EBMT)
    Mohty M [2015]
  • Serum tumor necrosis factor for monitoring response of hepatic veno-occlusive disease to pentoxiphyllin-a case report
    Parikh PM [1997]
  • Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/venoocclusive disease in adult patients : a new classification from the European Society for Blood and Marrow Transplantation
    Mohty M [2016]
  • Radiologic imaging and intervention for gastrointestinal and hepatic complications of hematopoietic stem cell transplantation
  • Prevention of regimen-related toxicities after bone marrow transplantation by pentoxifylline : a prospective, randomized trial
    Attal M [1993]
  • Phase I-II trial of pentoxifylline for the prevention of transplant-related toxicities following bone marrow transplantation
    Bianco JA [1991]
  • Pentoxifylline, ciprofloxacin and prednisone failed to prevent transplant-related toxicities in bone marrow transplant recipients and were associated with an increased incidence of infectious complications
    Ferra C [1997]
  • Pentoxifylline in the Treatment of Intermittent Claudication of the Lower Limbs
    Reich T [1984]
  • Pentoxifylline did not prevent transplantrelated toxicity in 31 consecutive allogeneic bone marrow transplant recipients
    Kalhs P [1992]
  • Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation
    Holler E [1990]
  • Immune response modulation by pentoxifylline in vitro
    Tilg H [1993]
  • Hepatic veno-occlusive disease after myeloablative treatment and bone marrow transplantation : value of gray-scale and Doppler US in 100 patients
    Lassau N [1997]
  • Hepatic Veno-occlusive disease after allogeneic bone marrow transplantation in patients with leukemia : risk factors and therapeutic effect of recombinant human tissue plasminogen activator
    Lee S [1999]
  • Clinical Pharmacology of Pentoxifylline With Special Reference to Its Hemorrheologic Effect for the Treatment of Intermittent Claudication
    Harold R. [1985]
  • Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxifylline
    Strieter RM [1988]
  • BCSH/BSBMT guideline : diagnosis and management of veno-occlusive disease(sinusoidal obstruction syndrome)following haematopoietic stem cell transplantation
    Dignan FL [2013]
  • A randomized controlled trial of pentoxifylline for the prevention of regimen-related toxicities in patients undergoing allogeneic marrow transplantation
    Clift RA [1993]